Table 4.
Proportion of First Nations individuals with type 2 diabetes and cardiovascular disease prescribed medications appropriate for secondary prevention for cardiovascular disease from communities participating in the Transformation of Indigenous Primary Healthcare Delivery (FORGE AHEAD) program
| Medication category | Individuals with cardiovascular disease (Total n = 164) | Women with cardiovascular disease (Total n = 73) | Men with cardiovascular disease (Total n = 91) | P |
|---|---|---|---|---|
| Aspirin or other antithrombotic | 59.2 (97) | 54.8 (40) | 62.6 (57) | 0.31 |
| Statin or other lipid-lowering medication | 48.2 (79) | 52.1 (38) | 45.1 (41) | 0.37 |
| Renin-angiotensin-aldosterone system inhibitor | 57.3 (94) | 56.2 (41) | 58.2 (53) | 0.79 |
| Beta-blocker | 20.1 (33) | 16.4 (12) | 23.1 (21) | 0.29 |
| All 4 classes of medications | 1.8 (3) | 2.7 (2) | 1.1 (1) | 0.44 |
Values are % (n), unless otherwise indicated.